RiverPark Advisors LLC Boosts Position in Zoetis Inc. $ZTS

RiverPark Advisors LLC grew its holdings in Zoetis Inc. (NYSE:ZTS) by 126.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,398 shares of the company’s stock after acquiring an additional 7,469 shares during the period. Zoetis comprises 1.3% of RiverPark Advisors LLC’s holdings, making the stock its 21st biggest position. RiverPark Advisors LLC’s holdings in Zoetis were worth $2,089,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Nuveen LLC acquired a new stake in Zoetis during the 1st quarter worth about $616,375,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in shares of Zoetis by 113.0% in the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,761,920 shares of the company’s stock worth $586,671,000 after buying an additional 1,995,491 shares during the last quarter. Polen Capital Management LLC grew its holdings in Zoetis by 17.6% during the first quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company’s stock worth $1,448,401,000 after acquiring an additional 1,313,653 shares during the period. Impax Asset Management Group plc raised its position in Zoetis by 362.6% during the second quarter. Impax Asset Management Group plc now owns 1,176,996 shares of the company’s stock valued at $182,705,000 after acquiring an additional 922,589 shares in the last quarter. Finally, Amundi raised its position in Zoetis by 30.8% during the first quarter. Amundi now owns 3,595,628 shares of the company’s stock valued at $575,691,000 after acquiring an additional 846,909 shares in the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

ZTS has been the topic of several recent research reports. KeyCorp assumed coverage on Zoetis in a research report on Thursday, November 20th. They issued a “sector weight” rating on the stock. Morgan Stanley dropped their price target on shares of Zoetis from $211.00 to $175.00 and set an “overweight” rating on the stock in a research report on Monday, November 10th. Stifel Nicolaus lowered their target price on shares of Zoetis from $140.00 to $130.00 and set a “hold” rating on the stock in a research note on Tuesday, November 18th. JPMorgan Chase & Co. reduced their price target on Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Zoetis in a research report on Wednesday, October 8th. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, Zoetis presently has a consensus rating of “Moderate Buy” and an average target price of $178.89.

Zoetis Trading Up 4.1%

Shares of Zoetis stock opened at $127.85 on Wednesday. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. Zoetis Inc. has a twelve month low of $115.25 and a twelve month high of $181.85. The firm has a market capitalization of $56.34 billion, a PE ratio of 22.01, a P/E/G ratio of 2.31 and a beta of 0.90. The firm’s 50-day moving average price is $136.89 and its 200 day moving average price is $149.63.

Zoetis (NYSE:ZTS) last announced its earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.08. The business had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.42 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The business’s revenue was up .5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.58 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, sell-side analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.6%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis’s payout ratio is 33.67%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.